InfiMed Therapeutics

InfiMed Therapeutics was a private Cambridge, Massachusetts specialty pharmaceutical and drug-delivery company focused on sustained-delivery formulations for protein and peptide therapeutics. The company appears to have built its business around an IFE drug-delivery technology using polyethylene glycol-based hydrogels to formulate improved delivery systems for biologics. Publicly available historical sources indicate that its early lead programs included recombinant human growth hormone formulations and oral insulin-related development efforts, and that it entered a collaboration with Praecis to combine its technology with Praecis's Rel-Ease platform. Available evidence suggests the company operated in the early 2000s, raised venture financing, and is no longer active as an operating biotech company.